Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMP False Claims Case Falters, But Pharma Isn’t In Clear Yet

This article was originally published in The Gold Sheet

Executive Summary

First appellate court ruling on the role of good manufacturing practice violations in False Claims Act suits could make future cases tougher, but legal experts still predict a flurry of such suits, with other jurisdictions weighing in. And the Justice Department has its own opinion on the matter.

Advertisement

Related Content

Ranbaxy’s $500 Million Settlement Includes Criminal Penalties
GMP Violations At GSK's Former Puerto Rico Plant Are Basis Of $750 Million DoJ Settlement

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS000858

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel